Presentation TCT 21: Prevalence, Presentation and Treatment of Balloon Undilatable Chronic Total Occlusions: Multicenter US Experience Presenter: Peter Tajti, MD October 31, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 CTO Up Next Presentation TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III Presenter: Ron Waksman October 31, 2017 More slides + Presentation TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings Presenter: Abraham Tzafriri, MD October 31, 2017 Presentation TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group Presenter: Krishnaraj Rathod, MD October 31, 2017 We Recommend
Presentation TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III Presenter: Ron Waksman October 31, 2017
Presentation TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings Presenter: Abraham Tzafriri, MD October 31, 2017
Presentation TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group Presenter: Krishnaraj Rathod, MD October 31, 2017